Robb Wesselingh

526 total citations
32 papers, 297 citations indexed

About

Robb Wesselingh is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Robb Wesselingh has authored 32 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Robb Wesselingh's work include Autoimmune Neurological Disorders and Treatments (14 papers), Peripheral Neuropathies and Disorders (7 papers) and RNA regulation and disease (5 papers). Robb Wesselingh is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (14 papers), Peripheral Neuropathies and Disorders (7 papers) and RNA regulation and disease (5 papers). Robb Wesselingh collaborates with scholars based in Australia, United States and Belgium. Robb Wesselingh's co-authors include Mastura Monif, Terence J. O’Brien, Helmut Butzkueven, David M. Tarlinton, James Broadley, Udaya Seneviratne, Carole Guillonneau, Philip D. Hodgkin, Alice E. Denton and David C. Jackson and has published in prestigious journals such as The Journal of Immunology, Journal of Neurology Neurosurgery & Psychiatry and Frontiers in Immunology.

In The Last Decade

Robb Wesselingh

28 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robb Wesselingh Australia 10 147 71 56 49 42 32 297
Allen D. DeSena United States 10 199 1.4× 45 0.6× 51 0.9× 36 0.7× 47 1.1× 14 361
Saskia Räuber Germany 8 129 0.9× 42 0.6× 40 0.7× 51 1.0× 63 1.5× 25 275
Eva Eliassen United States 7 111 0.8× 43 0.6× 78 1.4× 55 1.1× 27 0.6× 9 319
Grace Gombolay United States 11 178 1.2× 26 0.4× 24 0.4× 45 0.9× 25 0.6× 41 319
Itxaso Martì Spain 8 344 2.3× 28 0.4× 119 2.1× 55 1.1× 125 3.0× 20 534
Salvatore Cottone Italy 9 102 0.7× 28 0.4× 20 0.4× 33 0.7× 37 0.9× 24 333
Julien Hébert United States 8 211 1.4× 16 0.2× 42 0.8× 30 0.6× 39 0.9× 31 283
Thorsten Rosenkranz Germany 5 111 0.8× 23 0.3× 73 1.3× 97 2.0× 51 1.2× 8 394
Celalettin Korkmaz Türkiye 9 80 0.5× 31 0.4× 26 0.5× 73 1.5× 25 0.6× 26 265
Maria Cellerino Italy 11 147 1.0× 62 0.9× 13 0.2× 37 0.8× 37 0.9× 41 396

Countries citing papers authored by Robb Wesselingh

Since Specialization
Citations

This map shows the geographic impact of Robb Wesselingh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robb Wesselingh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robb Wesselingh more than expected).

Fields of papers citing papers by Robb Wesselingh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robb Wesselingh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robb Wesselingh. The network helps show where Robb Wesselingh may publish in the future.

Co-authorship network of co-authors of Robb Wesselingh

This figure shows the co-authorship network connecting the top 25 collaborators of Robb Wesselingh. A scholar is included among the top collaborators of Robb Wesselingh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robb Wesselingh. Robb Wesselingh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wesselingh, Robb, Jian Jian Li, T. Ian Simpson, et al.. (2025). Neurotoxicity associated with chimeric antigen receptor T-cell therapy. Journal of Neuroimmunology. 407. 578717–578717.
3.
4.
Costello, Daniel J., Elizabeth Matthews, Robb Wesselingh, et al.. (2024). Clinical outcomes among initial survivors of cryptogenic new‐onset refractory status epilepsy ( NORSE ). Epilepsia. 65(6). 1581–1588. 4 indexed citations
5.
Wesselingh, Robb, Udaya Seneviratne, Tomáš Kalinčík, et al.. (2024). Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms. Journal of Neurology. 271(8). 5610–5621. 2 indexed citations
6.
Wesselingh, Robb. (2023). Prevalence, pathogenesis and spectrum of neurological symptoms in COVID‐19 and post‐COVID‐19 syndrome: a narrative review. The Medical Journal of Australia. 219(5). 230–236. 10 indexed citations
7.
Wesselingh, Robb & Steve Wesselingh. (2023). An eye to the future: Acute and long‐term neuro‐ophthalmological and neurological complications of COVID‐19. Clinical and Experimental Ophthalmology. 51(4). 370–379. 3 indexed citations
8.
Wesselingh, Robb, James Broadley, David M. Tarlinton, et al.. (2023). Peripheral monocytes and soluble biomarkers in autoimmune encephalitis. Journal of Autoimmunity. 135. 103000–103000. 12 indexed citations
9.
Wesselingh, Robb, Wei Zhen Yeh, Olga Skibina, et al.. (2023). Neutropaenia complications from Ocrelizumab and Rituximab treatment. Multiple Sclerosis and Related Disorders. 81. 105147–105147. 8 indexed citations
10.
Wesselingh, Robb, Udaya Seneviratne, Helmut Butzkueven, et al.. (2023). Characterizing cognitive function in patients with autoimmune encephalitis: an Australian prospective study. Journal of Neurology. 271(1). 310–324. 7 indexed citations
11.
Wesselingh, Robb, James Broadley, David M. Tarlinton, et al.. (2022). Electroclinical biomarkers of autoimmune encephalitis. Epilepsy & Behavior. 128. 108571–108571. 2 indexed citations
12.
Wesselingh, Robb, James Broadley, Marie O’Shea, et al.. (2022). Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium. European Journal of Neurology. 29(8). 2355–2366. 6 indexed citations
13.
Wesselingh, Robb, James Broadley, David M. Tarlinton, et al.. (2022). Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis. Epilepsy & Behavior. 132. 108729–108729. 8 indexed citations
14.
Cheng, Allen, Helmut Butzkueven, Robb Wesselingh, et al.. (2021). Vaccinations in patients with multiple sclerosis: review and recommendations. The Medical Journal of Australia. 214(8). 350–350. 3 indexed citations
15.
Broadley, James, Robb Wesselingh, Udaya Seneviratne, et al.. (2021). Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis. Journal of Neuroimmunology. 353. 577508–577508. 9 indexed citations
16.
Broadley, James, Robb Wesselingh, Udaya Seneviratne, et al.. (2021). Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium. Frontiers in Immunology. 11(425). 48–597858. 23 indexed citations
17.
Carey, John P., Josephine Baker, Nicola Taylor, et al.. (2020). Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 47. 102642–102642. 10 indexed citations
18.
Pantelis, Christos, Mahesh Jayaram, Anthony J. Hannan, et al.. (2020). Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19. Australian & New Zealand Journal of Psychiatry. 55(8). 750–762. 30 indexed citations
19.
Wesselingh, Robb, et al.. (2019). Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?. Frontiers in Immunology. 10. 2066–2066. 58 indexed citations
20.
Wesselingh, Robb. (2008). From Milites Medici to Army Medics - a Two Thousand Year Tradition of Military Medicine. 16(4). 36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allen D. DeSena Breakdown of academic impact, for papers by Saskia Räuber Breakdown of academic impact, for papers by Eva Eliassen Breakdown of academic impact, for papers by Grace Gombolay Breakdown of academic impact, for papers by Itxaso Martì Breakdown of academic impact, for papers by Salvatore Cottone Breakdown of academic impact, for papers by Julien Hébert Breakdown of academic impact, for papers by Thorsten Rosenkranz Breakdown of academic impact, for papers by Celalettin Korkmaz Breakdown of academic impact, for papers by Maria Cellerino
Rankless by CCL
2026